IL-10 Beyond Immunosuppression: Unraveling Spatial, Cellular, and Metabolic Mechanisms of Gut Protection
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219472 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Yuchen Zhang und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China. Hauptthemen laut MEDLINE: Interleukin-10, Gastrointestinal Microbiome, Immune Tolerance, Intestinal Mucosa. Die Arbeit nennt 159 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Beijing Natural Science Foundation Program, National Natural Science Foundation of China, National Natural Science Foundation of China Grant.
Abstract (Originalsprache)
Intestinal homeostasis requires immune tolerance, barrier integrity, tissue repair, and microbiota mutualism. Interleukin-10 (IL-10) is essential, but not merely as an immunosuppressant. Although IL-10 signals via the IL-10R—JAK1/TYK2—STAT3 axis, its outputs are cell-type and context dependent. In macrophages, IL-10 restrains IL-23 production, inflammasome activation, IL-1β release, and metabolic reprogramming. In T cells, it limits pathogenic T helper 17 cell (Th17) responses while stabilizing regulatory cells and promoting metabolically driven IL-10 production. In the epithelium, IL-10 maintains barrier integrity by limiting apoptosis, endoplasmic reticulum (ER) stress, and mucus defects. IL-10 and the gut microbiota engage in reciprocal regulation: microbial metabolites and structural components enhance IL-10 production and receptor responsiveness, whereas IL-10 signaling preserves microbial diversity and ecological resilience. This may help to explain why systemic recombinant IL-10 failed in Crohn’s disease (CD)—increasing ligand abundance alone is unlikely to recapitulate endogenous localization or restore refractory target cells. Emerging strategies aim to tune IL-10 signaling through gut-selective delivery, engineered cytokines, conditionally activated prodrugs, regulatory cell approaches, and microbiome or metabolic interventions. Clinical translation requires biomarkers of IL-10R expression, STAT3 responsiveness, macrophage metabolic state, microbial signatures, and acquired IL-10 hyporesponsiveness. Despite the established role of IL-10 in intestinal homeostasis, systemic IL-10 therapy has failed in clinical trials, and there is a lack of effective strategies to restore IL-10 signaling in a spatially and cell-specific manner. The spatially organized, metabolically conditioned homeostatic IL-10 signaling—largely inferred from model systems and awaiting direct spatial validation in human intestine—offers a roadmap for more precise therapy in inflammatory bowel disease and related intestinal disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Medicine, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
- Department of Physiology and Pathophysiology, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
- Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Department of Gastrointestinal Oncology, Peking University Cancer Hospital & Institute, Beijing 100142, China.
- Department of Intelligent Medical Engineering, School of Biomedical Engineering, Capital Medical University, Beijing 100069, China.
- Experimental Centre for Morphological Research Platform, School of Basic Medical Sciences, Capital Medical University, Beijing 100069, China.
ORCID-Profile: Boya Wang, Haoyuan Yin, Xiang Tian, Xinyue Liu, Yuhang Bian, Sijin Gu, Haoxuan Zhang, Tong Wei, Lei Gao, Jingdong Xu
Förderung
- Beijing Natural Science Foundation Program
- National Natural Science Foundation of China
- National Natural Science Foundation of China Grant
Zitieren
APA
Zhang, Y., Liu, X., Wang, B., Yin, H., Tian, X., Zhao, J., Xin, S., Wang, H., Ren, Y., Liu, X., Liu, J., Bian, Y., Gu, S., Zhang, H., Wei, T., Gao, L., Lu, X., Shang, H., & Xu, J. (2026). IL-10 Beyond Immunosuppression: Unraveling Spatial, Cellular, and Metabolic Mechanisms of Gut Protection. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219472
Vancouver
Zhang Y, Liu X, Wang B, Yin H, Tian X, Zhao J, et al. IL-10 Beyond Immunosuppression: Unraveling Spatial, Cellular, and Metabolic Mechanisms of Gut Protection. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219472
BibTeX
@article{Zhang2026,
author = {Zhang, Yuchen and Liu, Xiaohui and Wang, Boya and Yin, Haoyuan and Tian, Xiang and Zhao, Jiatong and Xin, Shuzi and Wang, Hongli and Ren, Yushuo and Liu, Xinyue and Liu, Jingyu and Bian, Yuhang and Gu, Sijin and Zhang, Haoxuan and Wei, Tong and Gao, Lei and Lu, Xin and Shang, Hongwei and Xu, Jingdong},
title = {IL-10 Beyond Immunosuppression: Unraveling Spatial, Cellular, and Metabolic Mechanisms of Gut Protection},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219472}
}
EUVIMED